Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INCY Incyte Corp
- Stocks
- Healthcare
- NASDAQ: INCY
Price (delayed)
$63.31
Market cap
$12.25B
P/E Ratio
218.31
Dividend/share
N/A
EPS
$0.29
Enterprise value
$10.35B
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug,
Highlights
Incyte's revenue has increased by 17% YoY and by 4.1% from the previous quarter
INCY's gross profit is up by 17% year-on-year and by 4.1% since the previous quarter
INCY's P/E is 133% above its 5-year quarterly average of 93.6 but 27% below its last 4 quarters average of 297.2
INCY's EPS has shrunk by 91% YoY but it has soared by 81% QoQ
INCY's net income has dropped by 97% year-on-year and by 35% since the previous quarter
Key stats
What are the main financial stats of INCY
Market
Valuations
Earnings
Shares outstanding
193.57M
Market cap
$12.25B
Enterprise value
$10.35B
Price to earnings (P/E)
218.31
Price to book (P/B)
3.34
Price to sales (P/S)
2.78
EV/EBIT
32.63
EV/EBITDA
25.44
EV/Sales
2.34
Revenue
$4.41B
Gross profit
$4.09B
Operating income
$174.64M
Net income
$21.27M
EBIT
$317.17M
EBITDA
$406.83M
Free cash flow
$302.71M
Per share
Balance sheet
Liquidity
EPS
$0.29
EPS diluted
$0.25
Free cash flow per share
$1.56
Book value per share
$18.95
Revenue per share
$22.78
TBVPS
$28.32
Total assets
$5.75B
Total liabilities
$2.08B
Debt
$37.12M
Equity
$3.67B
Working capital
$1.79B
Debt to equity
0.01
Current ratio
2.04
Quick ratio
1.88
Net debt/EBITDA
-4.69
Margins
Efficiency
Dividend
EBITDA margin
9.2%
Gross margin
92.7%
Net margin
0.5%
Operating margin
4%
Return on assets
0.4%
Return on equity
0.6%
Return on invested capital
16.3%
Return on capital employed
7.9%
Return on sales
7.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INCY stock price
How has the Incyte stock price performed over time
Intraday
0.88%
1 week
7.34%
1 month
9.67%
1 year
11.34%
YTD
-8.34%
QTD
4.56%
Financial performance
How have Incyte's revenue and profit performed over time
Revenue
$4.41B
Gross profit
$4.09B
Operating income
$174.64M
Net income
$21.27M
Gross margin
92.7%
Net margin
0.5%
INCY's operating margin has surged by 186% since the previous quarter but it has dropped by 78% year-on-year
Incyte's operating income has soared by 185% from the previous quarter but it has plunged by 75% YoY
INCY's net income has dropped by 97% year-on-year and by 35% since the previous quarter
The net margin has dropped by 97% year-on-year and by 38% since the previous quarter
Price vs fundamentals
How does INCY's price correlate with its fundamentals
Growth
What is Incyte's growth rate over time
Valuation
What is Incyte stock price valuation
P/E
218.31
P/B
3.34
P/S
2.78
EV/EBIT
32.63
EV/EBITDA
25.44
EV/Sales
2.34
INCY's P/E is 133% above its 5-year quarterly average of 93.6 but 27% below its last 4 quarters average of 297.2
INCY's EPS has shrunk by 91% YoY but it has soared by 81% QoQ
INCY's equity is down by 32% year-on-year but it is up by 6% since the previous quarter
The stock's price to book (P/B) is 29% less than its 5-year quarterly average of 4.7 and 14% less than its last 4 quarters average of 3.9
INCY's P/S is 44% below its 5-year quarterly average of 5.0 and 10% below its last 4 quarters average of 3.1
Incyte's revenue has increased by 17% YoY and by 4.1% from the previous quarter
Efficiency
How efficient is Incyte business performance
The ROE has plunged by 96% YoY and by 33% from the previous quarter
INCY's return on assets has dropped by 96% year-on-year and by 33% since the previous quarter
INCY's ROS has shrunk by 73% YoY and by 4% QoQ
The ROIC has plunged by 69% YoY but it has increased by 3.2% from the previous quarter
Dividends
What is INCY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INCY.
Financial health
How did Incyte financials performed over time
Incyte's total assets is 176% more than its total liabilities
The company's quick ratio fell by 43% YoY but it rose by 2.2% QoQ
The current ratio has contracted by 41% YoY but it has grown by 3.6% from the previous quarter
The debt is 99% smaller than the equity
INCY's equity is down by 32% year-on-year but it is up by 6% since the previous quarter
The debt is up by 14% year-on-year but it is down by 2.2% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.